Worcester Polytechnic Institute researcher and BMES Fellow Kristen Billiar has been awarded a $154,000 grant from the American Heart Association to determine how cell death leads to calcium deposits in heart tissue that cause aortic valves to fail, the university announced.
The two-year project will involve laboratory experiments with cells grown in flat and three-dimensional shapes, and it will aim to discover ways to interrupt the process that leads to calcification and heart valve disease, according to the announcement.
The incidence and severity of aortic valve calcifications increase with age, and there is no way to cure the disease. Instead, a patient typically undergoes surgery to repair or replace the valve.
“We don't know why calcific nodules form, but one of the things correlated with it is programmed cell death,” Billiar said in the announcement. Billiar is a professor and head of the department of biomedical engineering. “We can use engineering techniques in reproducible experiments and see calcium depositing in cells like it does in valves. Now we want to know, what are the mechanisms involved in that?”
Read more HERE.

Gordana Vunjak-Novakovic Opens BMES Annual Meeting
This is the fifth in a series of articles highlighting some of the technologies, processes and keynote plenary sessions presented at the 2024 Annual...

NIH Prize Competitions: Crowdsourcing Biomedical Innovation
This is the sixth and final article in a series highlighting some of the technologies, processes and keynote plenary sessions presented at the 2024...

MICH. STATE AND STANFORD U RESEARCHERS DEVELOPING NANOPARTICLE TO EAT AWAY PORTIONS OF PLAQUES CAUSI
A nanotech therapy created by scientists at Michigan State University and Stanford University could eat away portions of the plaques that cause heart...

3 min read
Advancing Biomechanics: Innovations in Prosthetics, Heart Assist Devices, and Exoskeleton Technology
This is two in a series of articles highlighting some of the technologies, processes and keynote plenary sessions presented at the 2024 Annual...

NEW CLASSIFICATION SYSTEM DEVELOPED FOR REGENERATIVE CELL-BASED THERAPIES
Dr. Cato T. Laurencin, CEO of The Connecticut Convergence Institute for Translation in Regenerative Engineering at UConn Health, has created a new...